Asset
SAB-176
SAB Biotherapeutics Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT04471038 | phase1 | completed | 2020-07-29 | 2021-04-19 | SAb Biotherapeutics, Inc. | Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants |
| NCT04850898 | phase2 | completed | 2021-06-23 | 2021-10-08 | SAb Biotherapeutics, Inc. | Study of SAB-176 in Healthy Adult Participants |
FDA applications (0)
This company has no applications containing this asset.